Introduction

Discussion on a recent study by Novo Nordisk on weight loss drug WeGoV, its impact on cardiovascular disease, and positive developments in the field of weight loss drugs.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.